N-acetyl-S-(alpha-methyl-4-(2-methylpropyl)benzeneacetyl)cysteine 4-(nitrooxy)butyl ester clinical trials
How each study uses N-acetyl-S-(alpha-methyl-4-(2-methylpropyl)benzeneacetyl)cysteine 4-(nitrooxy)butyl ester is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the N-acetyl-S-(alpha-methyl-4-(2-methylpropyl)benzeneacetyl)cysteine 4-(nitrooxy)butyl ester studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- No aspirin
- 4
Studies by the year they started
5 studies that test it; most in 2022 (2)
| Year | Studies |
|---|---|
| 2002 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 4
- 5
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 0 · Other 5
Kyoto University, Graduate School of Medicine (1) · Kindai University (1) · Kumamoto University (1) · Takeshi Morimoto (1) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses N-acetyl-S-(alpha-methyl-4-(2-methylpropyl)benzeneacetyl)cysteine 4-(nitrooxy)butyl ester is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 5
- Efficacy and Safety of Aspirin in Patients With Chronic Coronary Syndromes Without RevascularizationRecruitingPhase 4Takeshi MorimotoNCT05347069Written as No aspirin
- Less Bleeding by Omitting Aspirin in Non-ST-segment Elevation Acute Coronary Syndrome PatientsRecruitingPhase 4Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)NCT05125276Written as No aspirin
- PRasugrEl Monotherapy Following prImary percUtaneous Coronary Intervention for ST-elevation Myocardial InfarctionCompletedPhase 4Kindai UniversityNCT05709626Written as No aspirin (Prasugurel monotherapy)
- ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-3 StudyActive, not recruitingPhase 4Kyoto University, Graduate School of MedicineNCT04609111Written as No aspirin
- Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes (JPAD) TrialCompletedPhase 4Kumamoto UniversityNCT00110448Written as No aspirin